tiprankstipranks
Aspen Pharmacare (APNHY)
OTHER OTC:APNHY

Aspen Pharmacare (APNHY) Stock Price & Analysis

14 Followers

APNHY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.36 - $12.31
Previous Close$12.31
Volume109.00
Average Volume (3M)179.00
Market Cap
$5.47B
Enterprise Value$6.48B
Total Cash (Recent Filing)Rs8.04B
Total Debt (Recent Filing)Rs26.80B
Price to Earnings (P/E)20.7
Beta0.76
Sep 03, 2024
EPS EstimateN/A
Dividend Yield1.04%
Share Statistics
EPS (TTM)0.59
Shares OutstandingN/A
10 Day Avg. Volume396
30 Day Avg. Volume179
Standard Deviation0.12
R-Squared0.27
Alpha0.00413
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%<0.01%99.99%
0.00%
Insiders
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

APNHY FAQ

What was Aspen Pharmacare’s price range in the past 12 months?
Aspen Pharmacare lowest stock price was $8.36 and its highest was $12.31 in the past 12 months.
    What is Aspen Pharmacare’s market cap?
    Currently, no data Available
    When is Aspen Pharmacare’s upcoming earnings report date?
    Aspen Pharmacare’s upcoming earnings report date is Sep 03, 2024 which is in 121 days.
      How were Aspen Pharmacare’s earnings last quarter?
      Aspen Pharmacare released its earnings results on Mar 04, 2024. The company reported $0.326 earnings per share for the quarter, beating the consensus estimate of N/A by $0.326.
        Is Aspen Pharmacare overvalued?
        According to Wall Street analysts Aspen Pharmacare’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Aspen Pharmacare pay dividends?
          Aspen Pharmacare pays a Annually dividend of $0.13 which represents an annual dividend yield of 1.04%. See more information on Aspen Pharmacare dividends here
            What is Aspen Pharmacare’s EPS estimate?
            Aspen Pharmacare’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Aspen Pharmacare have?
            Aspen Pharmacare has 446,252,320 shares outstanding.
              What happened to Aspen Pharmacare’s price movement after its last earnings report?
              Aspen Pharmacare reported an EPS of $0.326 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.078%.
                Which hedge fund is a major shareholder of Aspen Pharmacare?
                Currently, no hedge funds are holding shares in APNHY
                ---

                Aspen Pharmacare Stock Smart Score

                4
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                26.72%
                12-Months-Change

                Fundamentals

                Return on Equity
                5.80%
                Trailing 12-Months
                Asset Growth
                7.48%
                Trailing 12-Months

                Company Description

                Aspen Pharmacare

                Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the following segments: Therapeutic Focused Brands, Other Pharmaceuticals, and Nutritionals. The Therapeutic Focused Brands segment includes Anaesthetics and Thrombosis portfolios. The Nutritionals segment manufactures and markets in sub-Saharan Africa, Australia and Latin America. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
                ---

                APNHY Company Deck

                ---

                APNHY Earnings Call

                Q2 2024
                0:00 / 0:00
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Bristol-Myers Squibb
                Novartis
                GlaxoSmithKline
                AstraZeneca
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis